;

Articles Not Curated - Drug Studies-in vitro
Last updated: 2025 Mar 18
Total hit(s): 1262
S.No.
1
40590376
SARS-CoV-2 RNA-binding protein suppresses extracellular miRNA release.
RNA Biol
2025 Dec
1
2
40077853
Characterization of the binding features between SARS-CoV-2 5'-proximal transcripts of genomic RNA and nucleocapsid proteins.
RNA Biol
2025 Dec
1
3
40578708
Nonthermal plasma jet mitigates viral replication and inflammation in human coronavirus 229E-infected lung cells by targeting the NF-kappaB and MAPK pathways.
Microb Pathog
2025 Sep
2.64
1
4
40619617
Engineered Dual-Function Antibody-Like Proteins to Combat SARS-CoV-2-Induced Immune Dysregulation and Inflammation.
Adv Sci (Weinh)
2025 Jul 6
1
5
40252899
Discovery of cinnamoyl-flavonoid hybrid derivatives as inhibitors of SARS-CoV-2 M(pro) and anti-inflammatory agents: Experimental and in silico insights into their efficacy against lipopolysaccharide-induced lung injury.
Eur J Pharmacol
2025 Jul 5
3.24
1
6
40650237
Moloney Murine Leukemia Virus-like Nanoparticles Pseudo-Typed with SARS-CoV-2 RBD for Vaccination Against COVID-19.
Int J Mol Sci
2025 Jul 4
4.21
1
7
40676448
Intranasal delivery of engineered anti-SARS-CoV-2 extracellular vesicles therapeutically represses lung infection and inflammation.
Drug Deliv Transl Res
2025 Jul 17
1
8
40670289
Oral Administration of Water-Soluble Curcumin Complex Prevents ARDS With the Potential for COVID-19 Treatment.
Phytother Res
2025 Jul 16
7.5
1
9
40652684
SARS-CoV-2 vaccine failure rates and predictors of immune response in a diverse immunocompromised patient population.
Vaccine
2025 Jul 12
3.31
1
10
40594111
SARS-CoV-2 infection promotes lung thrombosis by inducing integrinbeta3 expression in vascular endothelial cells.
Sci Rep
2025 Jul 1
4.12
1
11
40596171
Antiviral and anti-inflammatory efficacy of nanoencapsulated brazilian green propolis against SARS-CoV-2.
Sci Rep
2025 Jul 1
4.12
1
12
40593736
Human protein interaction networks of ancestral and variant SARS-CoV-2 in organ-specific cells and bodily fluids.
Nat Commun
2025 Jul 1
11.8
1
13
40488359
Epidemiological changes of Mycoplasma pneumoniae among children before, during, and post the COVID-19 pandemic in Henan, China, from 2017 to 2024.
Microbiol Spectr
2025 Jun 9
4.6
1
14
40459233
Functional and structural characterization of treatment-emergent nirmatrelvir resistance mutations at low frequencies in the main protease (Mpro) reveals a unique evolutionary route for SARS-CoV-2 to gain resistance.
J Infect Dis
2025 Jun 3
4.73
1
15
40571942
The ACE2 decoy receptor can overcome immune escape by rapid mutating SARS-CoV-2 variants and reduce cytokine induction and clot formation.
J Biomed Sci
2025 Jun 26
15.5
1
16
40666984
PUM2 binds SARS-CoV-2 RNA and PUM1 mildly reduces viral RNA levels, but neither protein affects progeny virus production.
bioRxiv
2025 Jun 24
- n/a -
1
17
40549074
An in-vitro and in-silico approaches in exploring the molecular contact of COVID-19 antiviral drug molnupiravir with human serum albumin: effect of binding on protein structure.
J Comput Aided Mol Des
2025 Jun 23
1
18
40543162
Identification of nsp16 inhibitors of SARS -CoV-2, SARS -CoV-1 and MERS-CoV from FDA-approved drugs using in silico and in vitro methods.
Biomed Pharmacother
2025 Jun 20
3.83
1
19
40585204
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit.
Res Sq
2025 Jun 20
- n/a -
1
20
40547706
In Silico Discovery of a Novel Antiviral Scaffold for SARS-CoV2 Targeting the Spike Glycoprotein through the Fatty Acid Binding Pocket.
ACS Omega
2025 Jun 17
2.55
1
21
40503916
GSDMD and GSDME exhibit distinct roles in enteric coronavirus PDCoV-induced pyroptosis and inflammatory responses.
J Virol
2025 Jun 12
4.16
1
22
40498855
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates.
Sci Transl Med
2025 Jun 11
11.64
1
23
40254136
Lipid nanoparticles target neutrophils to reduce SARS-CoV-2-induced lung injury and inflammation.
J Control Release
2025 Jun 10
15.5
1
24
40160515
In silico studies to understand the interactions of flavonoid inhibitor with nsp12-RNA dependent RNA polymerase of SARS-CoV-2 and its homologs.
Biochem Biophys Rep
2025 Jun
1.65
1
25
40442985
Pathological Glucose Levels Enhance Entry Factor Expression and Hepatic SARS-CoV-2 Infection.
J Cell Mol Med
2025 Jun
4.59
1